Ascites, commonly known as water belly in the poultry industry, represents one of the most economically significant metabolic disorders affecting modern commercial broiler chickens worldwide. This condition is characterized by the abnormal accumulation of fluid within the abdominal cavity, resulting from right-sided heart failure secondary to pulmonary hypertension. The syndrome develops when the cardiovascular system cannot adequately meet the oxygen demands of rapidly growing tissues, creating a cascade of pathophysiological changes that ultimately prove fatal in affected birds. Understanding ascites requires appreciating the complex interactions between genetics, environment, nutrition, and management that determine whether individual birds develop this condition.
Ascites occurs primarily in fast-growing commercial broiler chickens, though it can affect turkeys and other poultry species under similar conditions of rapid growth and metabolic stress. The condition is most prevalent during cold weather when metabolic demands for thermoregulation compound the baseline oxygen requirements of rapid growth. Geographic regions at higher altitudes experience substantially greater ascites incidence due to reduced atmospheric oxygen availability, making this condition particularly problematic in poultry producing areas of Latin America, South Africa, and mountainous regions worldwide. Male broilers develop ascites more frequently than females due to their faster growth rates and larger body mass, creating greater oxygen demand relative to cardiovascular capacity.
The economic impact of ascites on commercial broiler production extends well beyond direct mortality losses to encompass condemnations at processing, reduced growth performance in subclinically affected birds, and the management costs associated with prevention programs. Industry estimates suggest ascites causes losses exceeding one billion dollars annually in the global broiler industry, making it one of the most costly metabolic conditions affecting commercial poultry. Welfare concerns add urgency to addressing this condition, as affected birds experience respiratory distress, exercise intolerance, and progressive decline that cause substantial suffering before death. The increasing prevalence of ascites has paralleled genetic progress in growth rate, highlighting the unintended consequences of single-trait selection programs.
Effective management of ascites requires comprehensive prevention strategies rather than treatment of affected individuals, as birds with established ascites cannot be cured and will inevitably die from the condition. Prevention focuses on managing growth rate through lighting programs, feed restriction, and diet manipulation while maintaining environmental conditions that minimize cardiovascular stress. Early recognition of increased ascites risk allows timely intervention through management adjustments that can substantially reduce losses. The ongoing challenge of balancing genetic potential for rapid growth against metabolic capacity limitations ensures that ascites will remain an important consideration in broiler production for the foreseeable future.
